Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,092 public trials 3,997 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

NCT04728893

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +24 more
Locations
  • Highlands Oncology Group ( Site 2728) Springdale, Arkansas, United States
  • University of California San Diego Moores Cancer Center ( Site 2717) La Jolla, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site 2724) Torrance, California, United States
  • Colorado Blood Cancer Institute ( Site 2726) Denver, Colorado, United States
View all 121 locations
View Trial Details
Recruiting

Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses

NCT07631598

Conditions
Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Community Health Project Los Angeles (CHPLA) Los Angeles, California, United States
  • HIPS Washington D.C., District of Columbia, United States
  • CARPBR/Be Safe Syringe Program Baton Rouge, Louisiana, United States
  • Harm Reduction Sisters Duluth, Minnesota, United States
View Trial Details
Recruiting

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

NCT04419649

Conditions
Bone Marrow Diseases, Cytopenia, Hematologic Diseases, +2 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of Miami School of Medicine Sylvester Comprehensive Cancer Center (SCCC) Miami, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Center Tampa, Florida, United States
  • Karmanos Cancer Institute at Mclaren Greater Lansing Lansing, Michigan, United States
View all 53 locations
View Trial Details
Recruiting

A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia

NCT07086976

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +5 more
Locations
  • Mayo Clinic in Arizona - Phoenix- Site Number : 8400032 Phoenix, Arizona, United States
  • Noble Clinical Research- Site Number : 8400003 Tucson, Arizona, United States
  • City of Hope National Medical Center- Site Number : 8400023 Duarte, California, United States
  • USC Norris Comprehensive Cancer Center- Site Number : 8400007 Los Angeles, California, United States
View all 95 locations
View Trial Details

Related conditions